Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 731, 135078
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and DementiaJournal of Nuclear Medicine, 2013
- Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targetsAgeing Research Reviews, 2012
- Soluble Oligomers of Amyloid-β Peptide Disrupt Membrane Trafficking of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse DysfunctionJournal of Biological Chemistry, 2011
- 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trialAnnals of Neurology, 2010
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptorsCell Calcium, 2010
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's diseaseInternational Psychogeriatrics, 2009
- Cerebrospinal fluid proteomic biomarkers for Alzheimer's diseaseAnnals of Neurology, 2006
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984